NPR : News

Filed Under:

Packaging Mix-Up For Birth Control Pills Prompts Recall

Here's a boo-boo that you just don't expect to happen at a company making prescription medicines — especially a firm called Qualitest Pharmaceuticals.

The Alabama-based maker of generic drugs apparently didn't do enough quality testing. It's recalling a slew of birth control pills because a mistake in the factory put pills in the wrong places inside plastic packages.

That mix-up means women could be getting the wrong pills during the month, leaving them "without adequate contraception, and at risk for unintended pregnancy," according to the company's notice about the recall.

The affected pills are:

  • Cyclafem 7/7/7
  • Cyclafem 1/35
  • Emoquette
  • Gildess FE 1.5/30
  • Gildess FE 1/20
  • Orsythia
  • Previfem
  • Tri-Previfem

To check the specific lots being recalled, see this list.

"The source of the error is currently under investigation and the company is committed to rectifying the issue in a timely manner," said the drugmaker, a unit of Endo Pharmaceuticals.

Copyright 2011 National Public Radio. To see more, visit


'Not Without My Daughter' Subject Grows Up, Tells Her Own Story

"Not Without My Daughter" told the story of an American mother and daughter fleeing Iran. Now that young girl is telling her own story in her memoir, "My Name is Mahtob."

Internet Food Culture Gives Rise To New 'Eatymology'

Internet food culture has brought us new words for nearly every gastronomical condition. The author of "Eatymology," parodist Josh Friedland, discusses "brogurt" with NPR's Rachel Martin.

Proposed Climate Change Rules At Odds With U.S. Opponents

President Obama says the U.S. must lead the charge to reduce burning of fossil fuels. But American lawmakers are divided on limiting carbon emissions and opponents say they'll challenge any new rules.

Payoffs For Prediction: Could Markets Help Identify Terrorism Risk?

In a terror prediction market, people would bet real money on the likelihood of attacks. NPR's Scott Simon speaks with Stephen Carter about whether such a market could predict — and deter — attacks.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.